
|Articles|October 1, 2010
Dermatology Times, Digital Edition, October 2010
EHRs, Worth the Hassle? : ‘Meaningful use’ criteria can pose high hurdle for derms Allergan Settles : Drugmaker to pay $600 million to resolve off-label marketing charges Special Report : Hair & Nails
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
2
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
3
When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria
4
Top 5 Articles of the Week: December 7-12
5


















